Summary.-The production of graft-versus-host (GVH) reactions in (PVGc x Wistar) F1 hybrids by the transfer of PVGc spleen cells resulted in significant resistance of these recipients to a subsequent challenge with the PVGC leukaemia. Protection was markedly dependent on dose and timing of allogeneic cell transfer and was abrogated by irradiation of the cells prior to transfer. GVH activity was shown to be a prerequisite for induction of the protective effect but was equally effective when produced by the transfer of Wistar spleen cells in place of PVGC cells.
Summary.-The production of graft-versus-host (GVH) reactions in (PVGc x Wistar) F1 hybrids by the transfer of PVGc spleen cells resulted in significant resistance of these recipients to a subsequent challenge with the PVGC leukaemia. Protection was markedly dependent on dose and timing of allogeneic cell transfer and was abrogated by irradiation of the cells prior to transfer. GVH activity was shown to be a prerequisite for induction of the protective effect but was equally effective when produced by the transfer of Wistar spleen cells in place of PVGC cells.
These points, plus the fact that in vitro investigations of possible immune mechanisms failed to demonstrate cytotoxic immunity in treated rats, suggested a nonspecific " bystander " effect as the mechanism of protection. The implications of such a mechanism are discussed.
THE DEMONSTRATIONS of increased immune responsiveness following allogeneic cell interactions (Hamilton, 1973; Katz, 1972) raised the question whether GVH reactions could have a similar effect on immune responses against tumours. Some evidence for this comes from several reports. Medzihradsky (1966) showed that the induction of a GVH reaction in (Lewis x AVN) F1 rats given the Walker tumour resulted in prolonged survival times and a decrease in the number of lethal takes of the tumour. Similar results were obtained with a methylcholanthrene-induced tumour when a GVH reaction was induced simultaneously with tumour inoculation (Medzihradsky, Konikova and Novotna, 1973) .
In guinea-pigs the transfer of allogeneic lymphoid cells has been shown to produce resistance to a subsequent inoculum of leukaemia cells. This resistance was manifested by striking prolongation of survival times and in some animals which survived indefinitely, resistance to a second chellenge with leukaemia was demonstrable. The effect was apparently dependent on a GVH reaction but attempts to determine the mechanisms involved were unsuccessful Katz et al., 1972) .
In many of the studies involving antitumour effects produced by the transfer of allogeneic cells, it has been difficult to divorce any direct cytotoxic effects the allogeneic cells may have on the tumour from the effects of interaction of allogeneic cells with those of the host. We have therefore chosen a GVH model in which the donor and recipient are histocompatible with the tumour and where the effects observed can presumably be attributed solely to the effects of the allogeneic interaction of lymphoid cells. We report here our results showing that interaction of lymphoid cells in a GVH reaction in these circumstances can result in marked inhibition of growth of a highly malignant leukaemia in rats. We have further characterized the nature of this anti-tumour activity and present the results of initial studies designed to reveal the mechanism of this effect. (Hersey, 1973a; 1973b Neonatal induction of tolerance. PVGC rats less than 24 h old were rendered neonatally tolerant of (PVGC x Wistar) F1 by the injection of 8 x 107 hybrid bone marrow cells via the intracardiac route, as described by Grazer (1958) .
Tolerance was assessed by a popliteal lymph node weight assay, described by Ford, Burr & Simonsen (1970) Antibody-dependent (AD) cell-mediated cytotoxicity. Assay of rat sera for this activity was carried out as previously described (Hersey, 1973b) using human effector cells obtained by Hypaque/Ficoll separation of peripheral blood. 6 x 105 effector cells in 0-2 ml were used in each assay and 2 x 104 target cells were added in 0-2 ml. Test sera from rats were added in serial concentrations in duplicate in a volume of 0 05 ml. The total volume of 0-45 ml was incubated in capped round-bottomed tubes for 6 h at 37°C. After this the cells were sedimented by centrifugation and 0 2 ml of each supernatant was transferred to adjacent tubes for counting. Direct cell-mediated cytotoxicity.-Spleen cells were assayed for direct cytotoxicity activity after depletion of macrophages by glass absorption (Hersey, 1973a) . Absorbed spleen cells at concentrations of 3 x 106 1 x 106 and 3 x 105 in 0 5 ml were added to target cells (2 x 104 in 0 5 ml). Incubation was for 6 h at 37°C in capped flatbottomed tubes. After incubation the cells w,ere centrifuged and 0 5 ml of supernatant transferred to adjacent tubes for counting. All counting was done on a Wallac Gamma Sample Counter.
Percent 51Cr release was calculated as follows: 0 51Cr release = x2
x 100 a + bx10 where a = activity in supernatant tube and b = activity in tube with cell pellet and remaining supernatant. For the direct cyto-toxic assay, the factor was 2 in place of 2-25.
In vitro assay for cytostatic serunt factors.-Spontaneous 3H-thymidine uptake by leukaemic cells w-as assessed by short-term culture of 3 x 106 cells in a volume of 1 ml of Dulbecco's modified Eagle's medium (DEM), supplemented with 10% FBS, penicillin and streptomycin. Cultures were pulsed for 4 h with 2 tCi of isotope at specific activity of 5 Ci/mM (Radiochemical Centre, Amersham) 2 h after the cultures were set up. Test and control serum was added in varying dilutions to these tubes at the time of dispensing tz determine whether such sera could produce a decrease in isotope uptake. Harvesting and counting were carried out by standard trichloroacetic acid extraction and : scintillation counting pro- 18, 18, 19, 24, 25 teraction of the cells was responsible for the effect.
The effect ofF1 spleen cells on leukaemia onset in PT'G. rats. Since protection was apparently dependent on an allogeneic cell interaction it was necessary to assess whether protection could be provided by the interaction of Parent and F1 cells in a HVG situation. When 108 F1 hybrid spleen cells were transferred to PVG, rats 6 days before leukaemic inoculation there was no significant difference between the time of leukaemia onset in these rats and in rats which received tumour cells only.
The effect of tolerant P VG. spleen cells. (Figure 3 .) The dependence of protection upon a GVH reaction was further investigated by assessing the effect of spleen cells from PVGC rats which had beeii rendered neonatally tolerant of (PVGC x Wistar) F1 and shown to be incapable of inducing a GVH respon.se in vtro. Rats given 10 8 tolerant spleen cells on Day 6 and 104 leukaemia cells on Day 0, failed to demonstrate a delay in onset of leukaemia, although 108 normal cells produced significant delay (P < 0.01). As a further control in this experiment a group of rats received 108 " nontolerant" cells from PVGC rats in which tolerance induction had failed and which were therefore able to produce GVH reactions in the in vivo GVH assay. As shown in Fig. 3 recipients of such cells showed a significant degree of delay, similar to that produced by normal PVGC cells.
AD cell-mediated cytotoxicity.-( Figure  4 .) Groups of F1 rats were given 108 PVGC spleen cells on Day 6 and serum samples taken on Days 0, + 6 and +12 in relation to the tumour inoculum. Samples from 3 individual rats were assayed at these time periods for evidence of AD cell-mediated cytotoxic activity and as shown in Fig. 4 (Woodruff and Nolan, 1963; Mathe et al., 1967; Boranic, 1968; Britton, 1972; Bortin, 1974) . The anti-leukaemia effect in these studies has generally been regarded as an example of adoptive immunotherapy, resulting from histocompatibility differ- ences between donor lymphoid cells and the tumour of the recipient. In contradistinction, the data presented here demonstrate an anti-leukaemic effect in a GVH reaction in which both donor and recipient are syngeneic with the leukaemia. The anti-leukaemic effect, in terms of delay in the time of leukaemia onset, was equivalent to a 3-4 log reduction in the size of the initial 104 leukaemia cell inoculum even though both PVGc and the F1 hybrid are incapable of rejecting inoculations of very small numbers of these tumour cells (Hersey, 1973c) .
Over the past few years several immunological effects of allogeneic cell interactions have been described, other than the anti-tumour effects described here. Increased antibody production after primary and secondary antigenic challenge has been described and referred to as the " allogeneic effect " (Katz, 1972; Hamilton, 1973) . Abrogation of tolerance has also been described under similar conditions by McCullagh (1970) . Similarities of the anti-tumour effect to these later phenomena are apparent.
The timing of the GVH reaction in relation to the challenge with tumour cells or antigen has been found critical in all studies and coincides with the time of peak GVH activity. Similarly the dosage of cells given to the recipients has also been shown to be important so that, in our own studies, if the parental cell inoculum was either too large or too small the effect was abrogated. Also, as in our own studies, irradiation of the donor cells rendered them much less effective in producing the described effect suggesting that viable cells capable of multiplication were needed.
In view of the similarities noted with these other described effects of allogeneic cell interactions, the question arises to what extent they can be implicated in the anti-tumour effect described in this model. To answer this question we have carried out in vitro studies to detect either direct cell-mediated or AD cellmediated immunity. Our failure to find any evidence of cytotoxic immunity by the assays argues against specific immune mechanisms being iinvolved but cannot be regarded as definitely excluding them. The assays used have been shown by previous studies (Hersey, 1973a, b) , and by the controls used in the present study to be sensitive in detection of these meclhanisms after allogeneic immunizations but could, nevertheless be ineffective in the semi-syngeneic model used here.
Another possible mechanism of the anti-tumouir effect considered in this study was that the F1 recipients recognized antigens on the PVGC spleen cells and were in effect being immunized against similar antigens on the PVTGC leukaemia. Although this contradicts classical transplantation dogma, the concept of aintiparental responses receives some support from the literature (Cudeowicz and Stimpfling, 1964; Field, Cauchi and Gibbs, 1967; Ramseier and Lindenmann, 1969) .
Several of the experiments described in this study argue strongly against this possibility. Firstly it was showin that PVGC cells tolerant to the F1 recipient did not give rise to any anti-tumour effects. As it seems likely that the tolerant cells have the same antigens as non-tolerant cells this argues against the effect being a result of recognition of parental antigens. Similarly the experiments using irradiated spleen cells can be interpreted in the same way. Even when 3 times the dose of irradiated cells was given the anti-leukaemic effect was still muich less than that resulting from a single (lose of unirradiated spleen cells. Secondly the kineties of the protection argues against an immunization effect, in that cells given 14 or 21 days before could be expected to provide a similar immunization to that at 6 davs. For further evidence against this mechanism the experiment using Wistar spleen cells can be cited. If immunization against PVGC spleen cells was involved, then XVistar spleen cells could be expected to be less effective than PVGc spleen cells. This was found not to be the case and equal protection was afforded by Wistar spleen cells.
We therefore consider the most likely explanation for the observed aniti-ttut iour effect is that it results from non-specific cytotoxic activity genierate1 durinig the course of the GVH reaction. Non-specific cytotoxic effects of GVH activity have been suggested by the in vivo stuidies of Elkins and Guttman (1968) and Streilein and Billingham (1970) . In vitro analyses of such effects by Sehan (1971, 1972) showed that non-specific cytotoxic effects were generated 4-8 days after parental cell transfer and were mediated by host cells. More receit demonstrations of similar effects were made by Britton-(1974) who founlfd evidence of in vitro cytotoxicity against syngeneic lymphoma cells in nice at the time of peak GVH activity. If our interpretation is correct it is clear that " non-specific " cytotoxic machanisms may play an effective role against tumour cells in vivo and may underlie the protective effect seen in several immunotherapy procedures involving trainsfer of allogeneic cells. If so, the measurement of non-specific (ytotoxicity against tumour cells may be of equal importance to that of specific immtune mechanisms in the evaluation of host resistance to tumours and in the icdevelopment of immunotherapy procedures.
